Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.86 - $6.98 $118,649 - $445,254
63,790 New
63,790 $435,000
Q3 2020

Nov 16, 2020

SELL
$81.91 - $134.94 $630,051 - $1.04 Million
-7,692 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$54.33 - $89.52 $417,906 - $688,587
7,692 New
7,692 $608,000
Q1 2020

May 15, 2020

SELL
$49.34 - $68.76 $221,043 - $308,044
-4,480 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$51.21 - $59.06 $255,896 - $295,122
-4,997 Reduced 52.73%
4,480 $242,000
Q3 2019

Nov 14, 2019

BUY
$40.6 - $57.2 $195,976 - $276,104
4,827 Added 103.81%
9,477 $495,000
Q2 2019

Aug 14, 2019

BUY
$39.92 - $53.86 $1,357 - $1,831
34 Added 0.74%
4,650 $225,000
Q1 2019

May 15, 2019

BUY
$48.23 - $66.16 $222,629 - $305,394
4,616 New
4,616 $233,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $384M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.